225 related articles for article (PubMed ID: 31479538)
1. An evaluation of nebulised amphotericin B deoxycholate (Fungizone
Otu AA; Langridge P; Denning DW
Mycoses; 2019 Nov; 62(11):1049-1055. PubMed ID: 31479538
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA).
Chishimba L; Langridge P; Powell G; Niven RM; Denning DW
J Asthma; 2015 Apr; 52(3):289-95. PubMed ID: 25158109
[TBL] [Abstract][Full Text] [Related]
3. Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review.
Godet C; Goudet V; Laurent F; Le Moal G; Gounant V; Frat JP; Cateau E; Roblot F; Cadranel J
Mycoses; 2015 Mar; 58(3):173-80. PubMed ID: 25690951
[TBL] [Abstract][Full Text] [Related]
4. Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis.
Leenders AC; de Marie S; ten Kate MT; Bakker-Woudenberg IA; Verbrugh HA
J Antimicrob Chemother; 1996 Aug; 38(2):215-25. PubMed ID: 8877535
[TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal Reflux Disease and Pulmonary Diseases Associated with Aspergillosis: Is There a Connection?
Gamaletsou MN; Denning DW
Mycopathologia; 2017 Dec; 182(11-12):1125-1129. PubMed ID: 28702854
[TBL] [Abstract][Full Text] [Related]
6. Fungal sensitisation in severe asthma is associated with the identification of Aspergillus fumigatus in sputum.
Farrant J; Brice H; Fowler S; Niven R
J Asthma; 2016 Sep; 53(7):732-5. PubMed ID: 27043956
[TBL] [Abstract][Full Text] [Related]
7. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
8. Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema.
Purcell IF; Corris PA
Thorax; 1995 Dec; 50(12):1321-3. PubMed ID: 8553311
[TBL] [Abstract][Full Text] [Related]
9. Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial.
Godet C; Couturaud F; Marchand-Adam S; Pison C; Gagnadoux F; Blanchard E; Taillé C; Philippe B; Hirschi S; Andréjak C; Bourdin A; Chenivesse C; Dominique S; Bassinet L; Murris-Espin M; Rivière F; Garcia G; Caillaud D; Blanc FX; Goupil F; Bergeron A; Gondouin A; Frat JP; Flament T; Camara B; Priou P; Brun AL; Laurent F; Ragot S; Cadranel J; ; Godet C; Couturaud F; Cadranel J; Frat JP; Brun AL; Laurent F; Marchand-Adam S; Pison C; Gagnadoux F; Blanchard E; Taillé C; Philippe B; Hirschi S; Andréjak C; Chenivesse C; Dominique S; Bassinet L; Murris-Espin M; Rivière F; Garcia G; Caillaud D; Blanc FX; Goupil F; Gondouin A; Flament T; Camara B; Priou P; Ragot S
Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34764182
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies on the efficacy of AmBisome and Fungizone in a mouse model of disseminated aspergillosis.
Takemoto K; Yamamoto Y; Ueda Y; Sumita Y; Yoshida K; Niki Y
J Antimicrob Chemother; 2004 Feb; 53(2):311-7. PubMed ID: 14729753
[TBL] [Abstract][Full Text] [Related]
11. Impact of high baseline Aspergillus-specific IgG levels on weight and quality-of-life outcomes of patients with chronic pulmonary aspergillosis.
Bongomin F; Garcez T; Denning DW
Med Mycol; 2020 Oct; 58(7):1000-1004. PubMed ID: 32343313
[TBL] [Abstract][Full Text] [Related]
12. An open-label non-inferiority randomised control trial comparing nebulised amphotericin B with oral itraconazole in patients with pulmonary aspergilloma.
Ray A; Manikanta J; Singh K; Gabra P; Vyas S; Singh G; Xess I; Sethi P; Meena VP; Soneja M; Sinha S; Wig N; Kabra SK
Mycoses; 2021 Sep; 64(9):1038-1044. PubMed ID: 34058036
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the LDBio Aspergillus ICT lateral flow assay for serodiagnosis of allergic bronchopulmonary aspergillosis.
Hunter ES; Page ID; Richardson MD; Denning DW
PLoS One; 2020; 15(9):e0238855. PubMed ID: 32976540
[TBL] [Abstract][Full Text] [Related]
14. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.
Stevens DA; Kan VL; Judson MA; Morrison VA; Dummer S; Denning DW; Bennett JE; Walsh TJ; Patterson TF; Pankey GA
Clin Infect Dis; 2000 Apr; 30(4):696-709. PubMed ID: 10770732
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.
Chishimba L; Niven RM; Cooley J; Denning DW
J Asthma; 2012 May; 49(4):423-33. PubMed ID: 22380765
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis.
Petraitis V; Petraitiene R; Lin P; Calis K; Kelaher AM; Muray HA; Mya-San C; Mickiene D; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2005 Apr; 49(4):1642-5. PubMed ID: 15793161
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, Biodistribution, and Nephrotoxicity of Experimental Amphotericin B-Deoxycholate Formulations for Pulmonary Aspergillosis.
López-Sánchez A; Pérez-Cantero A; Torrado-Salmerón C; Martin-Vicente A; García-Herrero V; González-Nicolás MÁ; Lázaro A; Tejedor A; Torrado-Santiago S; García-Rodríguez JJ; Capilla J; Torrado S
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760126
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response.
Becker MJ; de Marie S; Fens MH; Hop WC; Verbrugh HA; Bakker-Woudenberg IA
J Antimicrob Chemother; 2002 May; 49(5):813-20. PubMed ID: 12003976
[TBL] [Abstract][Full Text] [Related]
19. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]